Urinary Fatty Acid Binding Protein 2 (FABP2) as a Biomarker of Intestinal Injury in Pediatric Celiac Disease - Top-Institutions - MDSpire

Urinary Fatty Acid Binding Protein 2 (FABP2) as a Biomarker of Intestinal Injury in Pediatric Celiac Disease

  • By

  • Mehta, Vijay

  • Kapoor, Nidhi

  • Milliron, Chloe

  • Stoeckel, Noah

  • Ballelos, Edwin

  • Tiqui, Katrina

  • Deb, Chirajyoti

  • Abomoelak, Bassam

  • Schreck, Mary

  • Mehta, Devendra

  • May 20, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Pediatric Gastroenterology
    • Pediatrics

  • #2

    Nationwide Children’s Hospital
    Nationwide Children’s Hospital

    Columbus, Ohio

    Key Differentiators

    • Pediatric Gastroenterology
    • Pediatrics

  • #3

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Gastroenterology
    • Pediatrics

  • #4

    University of Chicago
    University of Chicago

    Chicago, Illinois

    Key Differentiators

    • Pediatric Gastroenterology
    • Pediatrics

  • #5

    Medical University of Gdańsk
    Medical University of Gdańsk

    Gdańsk, Poland

    Key Differentiators

    • Pediatric Gastroenterology
    • Pediatrics

Original Source(s)

Urinary Fatty Acid Binding Protein 2 (FABP2) as a Biomarker of Intestinal Injury in Pediatric Celiac Disease

  • by Mehta, Vijay , Kapoor, Nidhi , Milliron, Chloe , Stoeckel, Noah , Ballelos, Edwin , Tiqui, Katrina , Deb, Chirajyoti , Abomoelak, Bassam , Schreck, Mary , Mehta, Devendra

  • May 20, 2026

Related Content

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report

Case Report: Endoscopic ultrasound in the diagnosis and endoscopic treatment of a delayed-presentation duodenal web in a toddler